Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD+ co-factor binding
Wirawan, R., Frei, M., Heider, A., Papenkordt, N., Friedrich, F., Wein, T., Jung, M., Groll, M., huber, E., Bracher, F.(2025) RSC Med Chem 
- DOI: https://doi.org/10.1039/D5MD00144G